Search Results
A-type Natriuretic Peptide (1-30), frog 1 mg | ≥95%
LKT Laboratories, Inc.
A-type Natriuretic Peptide (1-30), frog 0.5 mg | ≥95%
LKT Laboratories, Inc.
A-type Natriuretic Peptide (1-11), rat 5 mg | ≥95%
LKT Laboratories, Inc.
A-type Natriuretic Peptide (1-11), rat 2 mg | ≥95%
LKT Laboratories, Inc.
Angiotensin II (3-8), human 25 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide fragment, involved in vasoconstriction, Na+ reabsorption, and blood pressure; AT1 agonist, Na+/H+ transporter activator.
More Information Supplier PageAngiotensin II (3-8), human 10 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide fragment, involved in vasoconstriction, Na+ reabsorption, and blood pressure; AT1 agonist, Na+/H+ transporter activator.
More Information Supplier PageAngiotensin II (3-8), human 5 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide fragment, involved in vasoconstriction, Na+ reabsorption, and blood pressure; AT1 agonist, Na+/H+ transporter activator.
More Information Supplier PageAngiotensin II (1-4), human 25 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide fragment, involved in vasoconstriction, Na+ reabsorption, and blood pressure; AT1 agonist, Na+/H+ transporter activator.
More Information Supplier PageAngiotensin II (1-4), human 10 mg | ≥95%
LKT Laboratories, Inc.
Endogenous peptide fragment, involved in vasoconstriction, Na+ reabsorption, and blood pressure; AT1 agonist, Na+/H+ transporter activator.
More Information Supplier Page